MarketPulse

metastatic cancer

2 articles
BenzingaBenzinga··Vandana Singh

Pfizer's Breast Cancer Drug Hits Survival Goals as Oncology Pipeline Accelerates

Pfizer reports positive Phase 2 data for atirmociclib in metastatic breast cancer, meeting survival endpoints. Company also gains FDA approval for Braftovi in colorectal cancer.
PFEcolorectal cancerFDA approval
BenzingaBenzinga··Vandana Singh

Pfizer's Braftovi Regimen Achieves Primary Endpoints in Metastatic Colorectal Cancer Trial

Pfizer's Braftovi regimen met primary endpoints in Phase 3 colorectal cancer trial, showing significant improvements in progression-free survival versus standard chemotherapy in BRAF-mutated patients.
PFEFDLPJPcolorectal cancerBraftovi